Free Trial

Tenaya Therapeutics (TNYA) SEC Filings & 10K Form

$2.13
-0.06 (-2.74%)
(As of 09/20/2024 ET)

Recent Tenaya Therapeutics SEC Filings

DateFilerForm TypeView
09/17/2024
5:26 AM
Tenaya Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/19/2024
7:30 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:23 PM
Saito Chihiro (Reporting)
Tenaya Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2024
7:23 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
7:24 PM
Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
7:25 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
7:26 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:24 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2024
3:02 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
4:10 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:15 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:09 PM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2024
3:58 PM
Tenaya Therapeutics (Filer)
Form ARS
04/17/2024
3:15 PM
Tenaya Therapeutics (Filer)
Form DEF 14A
04/17/2024
3:17 PM
Tenaya Therapeutics (Filer)
Form DEFA14A
03/06/2024
5:45 PM
Hoey Timothy (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:28 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:29 PM
PATTERSON LEONE D (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:30 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:31 PM
Hoey Timothy (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
5:05 PM
Hoey Timothy (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:32 PM
PATTERSON LEONE D (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:35 PM
Tenaya Therapeutics (Issuer)
Tingley Whittemore (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:37 PM
Hoey Timothy (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:30 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
7:11 PM
PATTERSON LEONE D (Reporting)
Tenaya Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
7:13 PM
Tenaya Therapeutics (Subject)
Tingley Whittemore (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
7:06 PM
Ali Faraz (Reporting)
Tenaya Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
6:29 AM
RTW INVESTMENTS, LP (Filed by)
Tenaya Therapeutics (Subject)
Form SC 13G/A
02/08/2024
4:25 PM
Tenaya Therapeutics (Filer)
Form 424B5
02/08/2024
7:15 AM
Tenaya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:11 PM
Tenaya Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/31/2024
1:08 PM
BlackRock Inc. (Filed by)
Tenaya Therapeutics (Subject)
Form SC 13G
11/08/2023
3:21 PM
Tenaya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TNYA) was last updated on 9/20/2024 by MarketBeat.com Staff
From Our Partners